I did listen to this webinar. There were three presenters,
Endpoints has just put up the questions asked, and answers, this was not on the webinar, and is interesting reading.
I will put a link here. The last point , i.e. , the relative ease , for running trials in OV therapy, with an IV dose needing .
minutes, compared to IV infusion in a clinic for four hours, is worth noting.
A brief summary:
Paul Peter Tak, Candel therapeutics, works with HSV virus, trial in Prostate cancer, IT , no IV. Study started 2011, completing Dec 2024 . ( talk about needing patience) also study into glioblastoma.
Howard Kaufman , CEO Ankara, also intratumoral only. Only “ clinical” work has been in dogs! Humans” coming soon”
Adina Pelusio . With KaliVir.. also using vaccinia, working on IV use. Again only clinical work in dogs. An unlisted company. She was impressive.
issuses discussed were , needing good study design, targeting the right tumour, RECIST esp tumour size, with regard to tumour pseudo progression.
All this prompted me to have a good look at T-VEC. AMGEN is a huge company, T-VEC is a good earner, but by no means their most important. Notably, they have no ongoing research into OV’s. I guess they just buy out what they want.
All up, I think if there is another update webinar in this field, I believe that YF will be invited . OV’s are a tough field, these speakers have been in it for decades. I’m feeling very good about CF 33 , etc
https://endpts.com/oncolytic-virus-experts-discuss-biggest-lessons-from-past-failures/
- Forums
- ASX - By Stock
- IMU
- Ann: Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study
Ann: Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study, page-102
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
5.1¢ | 5.1¢ | 4.8¢ | $1.062M | 21.65M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 5138497 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 6291273 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 5138497 | 0.048 |
22 | 3143081 | 0.047 |
29 | 3847736 | 0.046 |
32 | 6541751 | 0.045 |
6 | 3324000 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 6291273 | 3 |
0.050 | 1449728 | 13 |
0.051 | 310515 | 4 |
0.052 | 162748 | 5 |
0.053 | 2515148 | 9 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |